Paris, France

Sylvie Gisselbrecht


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sylvie Gisselbrecht: Innovator in Molecular Detection

Introduction

Sylvie Gisselbrecht is a prominent inventor based in Paris, France. She has made significant contributions to the field of molecular detection, particularly in the area of growth factor receptors. With a total of 2 patents, her work has implications for both research and medical diagnostics.

Latest Patents

Gisselbrecht's latest patents include innovative methods for the detection of molecules with affinity for MPL polypeptides. One of her notable inventions is a polypeptide of a growth factor receptor family, which has a specific sequence and presents properties that encourage and/or are involved in the proliferation and/or differentiation of hematopoietic cell lines when obtained from the MPLV retrovirus. This polypeptide is capable of acting as a hematopoietic growth factor receptor and is recognized by antibodies directed against it. Additionally, she has developed nucleic acids encoding polypeptides of a growth factor receptor family, which have applications in diagnosing the expression of said ligand polypeptide.

Career Highlights

Sylvie Gisselbrecht is affiliated with the Institut National de la Santé et de la Recherche Médicale, where she continues her research and development efforts. Her work has garnered attention in the scientific community for its potential applications in healthcare and diagnostics.

Collaborations

Gisselbrecht has collaborated with notable colleagues, including Martine Charon and Jean-François Penciolelli. These collaborations have further enriched her research and contributed to the advancement of her innovative projects.

Conclusion

Sylvie Gisselbrecht stands out as a key figure in the field of molecular detection, with her patents paving the way for advancements in medical diagnostics. Her contributions reflect the importance of innovation in addressing complex biological challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…